Atlas Trials

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Clinical trial NCT05451173 · UNKNOWN

Trial details

NCT number
NCT05451173
Sponsor
Alexander Chi
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung CancerNon-small Cell CarcinomaNon-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage III
Start date
2023-10-09
Primary completion
2025-12-31
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.